Macrogenics (MGNX) Misses Q1 EPS by 110c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.61), $1.10 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $24.5 million versus the consensus estimate of $106.5 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance